Tapewire

Nasdaq · USD

NBIX

NEUROCRINE BIOSCIENCES INC

Export transactions ↓
Tapewire entity
2655
SEC CIK
0000914475
Parsed reports
676

Last 12 months

Inside the activity.

0 purchase rows · 40 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202504
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202606
Jun 2026015
Jul 202606
Aug 202600
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 22, 2024 Filed May 23, 2024 21:59 UTC GrantRestricted Stock Unit · Derivative 1,435 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000142 · wk-form4_1716501535.xml · derivative · entry 1

Mercier Johanna · CIK 0001782135 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,435

Underlying: Common Stock · 1,435 shares

Expires not disclosed

F1 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: The RSUs will vest in full on May 22, 2025.

F2 · derivative.expiration_date: The RSUs will vest in full on May 22, 2025.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:35 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,100 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000138 · wk-form4_1716327316.xml · derivative · entry 3

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.

F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:35 UTC SaleCommon Stock 1,106 $141.90 $156,943.39
Disclosure

SEC source: 0000914475-24-000138 · wk-form4_1716327316.xml · nonDerivative · entry 2

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 994

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.81 to $142.33. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range

Read SEC document
May 17, 2024 Filed May 21, 2024 21:35 UTC Exercise / conversionCommon Stock 2,100 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000138 · wk-form4_1716327316.xml · nonDerivative · entry 1

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:27 UTC Exercise / conversionRestricted Stock Unit · Derivative 4,199 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000136 · wk-form4_1716326835.xml · derivative · entry 3

POPS RICHARD F · CIK 0001126490 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,199 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:27 UTC SaleCommon Stock 2,100 $141.84 $297,860.43
Disclosure

SEC source: 0000914475-24-000136 · wk-form4_1716326835.xml · nonDerivative · entry 2

POPS RICHARD F · CIK 0001126490 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,611

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.80 to $142.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range

Read SEC document
May 17, 2024 Filed May 21, 2024 21:27 UTC Exercise / conversionCommon Stock 4,199 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000136 · wk-form4_1716326835.xml · nonDerivative · entry 1

POPS RICHARD F · CIK 0001126490 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,711

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:15 UTC Exercise / conversionRestricted Stock Unit · Derivative 4,199 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000134 · wk-form4_1716326089.xml · derivative · entry 2

MORROW GEORGE J · CIK 0001068754 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,199 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:15 UTC Exercise / conversionCommon Stock 4,199 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000134 · wk-form4_1716326089.xml · nonDerivative · entry 1

MORROW GEORGE J · CIK 0001068754 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,199

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:57 UTC
LYONS GARY ADirector
Exercise / conversionRestricted Stock Unit · Derivative 2,100 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000129 · wk-form4_1716325029.xml · derivative · entry 2

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F3 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

F3 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:57 UTC
LYONS GARY ADirector
Exercise / conversionCommon Stock 2,100 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000129 · wk-form4_1716325029.xml · nonDerivative · entry 1

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: 110,964 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:06 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,100 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000132 · wk-form4_1716325570.xml · derivative · entry 3

Norwalk Leslie V · CIK 0001533568 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:06 UTC SaleCommon Stock 1,106 $141.82 $156,849.93
Disclosure

SEC source: 0000914475-24-000132 · wk-form4_1716325570.xml · nonDerivative · entry 2

Norwalk Leslie V · CIK 0001533568 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 994

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.81 to $142.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range

Read SEC document
May 17, 2024 Filed May 21, 2024 21:06 UTC Exercise / conversionCommon Stock 2,100 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000132 · wk-form4_1716325570.xml · nonDerivative · entry 1

Norwalk Leslie V · CIK 0001533568 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:51 UTC Exercise / conversionRestricted Stock Unit · Derivative 4,199 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000127 · wk-form4_1716324649.xml · derivative · entry 2

SHERWIN STEPHEN A · CIK 0001079462 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,199 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:51 UTC Exercise / conversionCommon Stock 4,199 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000127 · wk-form4_1716324649.xml · nonDerivative · entry 1

SHERWIN STEPHEN A · CIK 0001079462 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,504

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:46 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,100 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000125 · wk-form4_1716324372.xml · derivative · entry 2

Mercier Johanna · CIK 0001782135 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:46 UTC Exercise / conversionCommon Stock 2,100 $0.00 $0.00
Disclosure

SEC source: 0000914475-24-000125 · wk-form4_1716324372.xml · nonDerivative · entry 1

Mercier Johanna · CIK 0001782135 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2024 Filed May 16, 2024 20:40 UTC
ABERNETHY MATTChief Financial Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 15,000 $73.60 Strike: $73.60 $1,104,000.00
Disclosure

SEC source: 0000914475-24-000121 · wk-form4_1715892031.xml · derivative · entry 6

ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option granted December 1, 2017 and vested at 25% upon first anniversary (December 1, 2018) and the remaining 75% vested in 36 equal monthly installments beginning November 1, 2018.

Read SEC document
May 15, 2024 Filed May 16, 2024 20:40 UTC
ABERNETHY MATTChief Financial Officer
SaleCommon Stock 15,000 $140.24 $2,103,609.00
Disclosure

SEC source: 0000914475-24-000121 · wk-form4_1715892031.xml · nonDerivative · entry 4

ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,528

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.48. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 15, 2024 Filed May 16, 2024 20:40 UTC
ABERNETHY MATTChief Financial Officer
Exercise / conversionCommon Stock 15,000 $73.60 $1,104,000.00
Disclosure

SEC source: 0000914475-24-000121 · wk-form4_1715892031.xml · nonDerivative · entry 3

ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:55 UTC
LYONS GARY ADirector
Exercise / conversionNon-Qualified Stock Option · Derivative 12,500 $42.76 Strike: $42.76 $534,500.00
Disclosure

SEC source: 0000914475-24-000123 · wk-form4_1715892908.xml · derivative · entry 3

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2025-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option was granted May 28, 2015 and vested in 12 equal monthly installments beginning June 28, 2015. These options will expire ten years from the date of grant on May 28, 2025.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:55 UTC
LYONS GARY ADirector
SaleCommon Stock 12,500 $135.63 $1,695,370.00
Disclosure

SEC source: 0000914475-24-000123 · wk-form4_1715892908.xml · nonDerivative · entry 2

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,947

F3 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2024.

F4 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $134.78 to $137.12. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2 · ownership.direct: 110,964 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:55 UTC
LYONS GARY ADirector
Exercise / conversionCommon Stock 12,500 $42.76 $534,500.00
Disclosure

SEC source: 0000914475-24-000123 · wk-form4_1715892908.xml · nonDerivative · entry 1

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,447

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: Reflects a decrease of 76,750 shares from the amount previously reported as beneficially owned, which was recently discovered to be overstated due to an administrative oversight.

F2 · ownership.direct: 110,964 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:40 UTC
ABERNETHY MATTChief Financial Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 15,000 $73.60 Strike: $73.60 $1,104,000.00
Disclosure

SEC source: 0000914475-24-000121 · wk-form4_1715892031.xml · derivative · entry 5

ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 15,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option granted December 1, 2017 and vested at 25% upon first anniversary (December 1, 2018) and the remaining 75% vested in 36 equal monthly installments beginning November 1, 2018.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:40 UTC
ABERNETHY MATTChief Financial Officer
SaleCommon Stock 15,000 $135.66 $2,034,826.50
Disclosure

SEC source: 0000914475-24-000121 · wk-form4_1715892031.xml · nonDerivative · entry 2

ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,528

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $135.00 to $137.12. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:40 UTC
ABERNETHY MATTChief Financial Officer
Exercise / conversionCommon Stock 15,000 $73.60 $1,104,000.00
Disclosure

SEC source: 0000914475-24-000121 · wk-form4_1715892031.xml · nonDerivative · entry 1

ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 06, 2024 Filed May 8, 2024 20:26 UTC
Delaet IngridChief Regulatory Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 273 $79.02 Strike: $79.02 $21,572.46
Disclosure

SEC source: 0000914475-24-000119 · wk-form4_1715200000.xml · derivative · entry 3

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,899

Underlying: Common Stock · 273 shares

Expires 2032-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032.

Read SEC document
May 06, 2024 Filed May 8, 2024 20:26 UTC
Delaet IngridChief Regulatory Officer
SaleCommon Stock 273 $140.55 $38,370.15
Disclosure

SEC source: 0000914475-24-000119 · wk-form4_1715200000.xml · nonDerivative · entry 2

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,507

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023.

Read SEC document
May 06, 2024 Filed May 8, 2024 20:26 UTC
Delaet IngridChief Regulatory Officer
Exercise / conversionCommon Stock 273 $79.02 $21,572.46
Disclosure

SEC source: 0000914475-24-000119 · wk-form4_1715200000.xml · nonDerivative · entry 1

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,780

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:19 UTC
BENEVICH ERICChief Commercial Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 12,587 $81.05 Strike: $81.05 $1,020,176.35
Disclosure

SEC source: 0000914475-24-000111 · wk-form4_1713388780.xml · derivative · entry 6

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,587 shares

Expires 2029-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option was granted February 7, 2019 and vested in 48 equal monthly installments beginning March 7, 2019. These options will expire ten years from the date of grant on February 07, 2029.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:19 UTC
BENEVICH ERICChief Commercial Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 7,231 $81.49 Strike: $81.49 $589,254.19
Disclosure

SEC source: 0000914475-24-000111 · wk-form4_1713388780.xml · derivative · entry 5

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,292

Underlying: Common Stock · 7,231 shares

Expires 2028-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option was granted February 5, 2018 and vested in 48 equal monthly installments beginning March 5, 2018. These options will expire ten years from the date of grant on February 05, 2028.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:19 UTC
BENEVICH ERICChief Commercial Officer
SaleCommon Stock 12,587 $133.36 $1,678,660.22
Disclosure

SEC source: 0000914475-24-000111 · wk-form4_1713388780.xml · nonDerivative · entry 4

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,778

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $131.56 to $136.47. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:19 UTC
BENEVICH ERICChief Commercial Officer
Exercise / conversionCommon Stock 12,587 $81.05 $1,020,176.35
Disclosure

SEC source: 0000914475-24-000111 · wk-form4_1713388780.xml · nonDerivative · entry 3

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:19 UTC
BENEVICH ERICChief Commercial Officer
SaleCommon Stock 7,231 $133.36 $964,359.42
Disclosure

SEC source: 0000914475-24-000111 · wk-form4_1713388780.xml · nonDerivative · entry 2

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,778

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $131.56 to $136.47. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:19 UTC
BENEVICH ERICChief Commercial Officer
Exercise / conversionCommon Stock 7,231 $81.49 $589,254.19
Disclosure

SEC source: 0000914475-24-000111 · wk-form4_1713388780.xml · nonDerivative · entry 1

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 20:44 UTC
Delaet IngridChief Regulatory Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 272 $79.02 Strike: $79.02 $21,493.44
Disclosure

SEC source: 0000914475-24-000100 · wk-form4_1712177026.xml · derivative · entry 3

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,172

Underlying: Common Stock · 272 shares

Expires 2032-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 20:44 UTC
Delaet IngridChief Regulatory Officer
SaleCommon Stock 272 $137.30 $37,345.60
Disclosure

SEC source: 0000914475-24-000100 · wk-form4_1712177026.xml · nonDerivative · entry 2

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,507

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 20:44 UTC
Delaet IngridChief Regulatory Officer
Exercise / conversionCommon Stock 272 $79.02 $21,493.44
Disclosure

SEC source: 0000914475-24-000100 · wk-form4_1712177026.xml · nonDerivative · entry 1

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,779

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 21, 2024 Filed Mar 25, 2024 22:02 UTC
Delaet IngridChief Regulatory Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 5,000 $103.52 Strike: $103.52 $517,600.00
Disclosure

SEC source: 0000914475-24-000098 · wk-form4_1711404161.xml · derivative · entry 3

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,049

Underlying: Common Stock · 5,000 shares

Expires 2033-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.

Read SEC document
March 21, 2024 Filed Mar 25, 2024 22:02 UTC
Delaet IngridChief Regulatory Officer
SaleCommon Stock 5,000 $145.06 $725,320.00
Disclosure

SEC source: 0000914475-24-000098 · wk-form4_1711404161.xml · nonDerivative · entry 2

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,507

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Transactions at prices ranging from $145.00 to $145.24. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 21, 2024 Filed Mar 25, 2024 22:02 UTC
Delaet IngridChief Regulatory Officer
Exercise / conversionCommon Stock 5,000 $103.52 $517,600.00
Disclosure

SEC source: 0000914475-24-000098 · wk-form4_1711404161.xml · nonDerivative · entry 1

Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,507

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:33 UTC
BENEVICH ERICChief Commercial Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 69,521 $81.05 Strike: $81.05 $5,634,677.05
Disclosure

SEC source: 0000914475-24-000096 · wk-form4_1710538413.xml · derivative · entry 6

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,587

Underlying: Common Stock · 69,521 shares

Expires 2029-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option was granted February 7, 2019 and vested in 48 equal monthly installments beginning March 7, 2019. These options will expire ten years from the date of grant on February 07, 2029.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:33 UTC
BENEVICH ERICChief Commercial Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 5,479 $79.02 Strike: $79.02 $432,950.58
Disclosure

SEC source: 0000914475-24-000096 · wk-form4_1710538413.xml · derivative · entry 5

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,881

Underlying: Common Stock · 5,479 shares

Expires 2032-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:33 UTC
BENEVICH ERICChief Commercial Officer
SaleCommon Stock 69,521 $139.38 $9,689,760.51
Disclosure

SEC source: 0000914475-24-000096 · wk-form4_1710538413.xml · nonDerivative · entry 4

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,778

F2 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $137.83 to $142.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:33 UTC
BENEVICH ERICChief Commercial Officer
Exercise / conversionCommon Stock 69,521 $81.05 $5,634,677.05
Disclosure

SEC source: 0000914475-24-000096 · wk-form4_1710538413.xml · nonDerivative · entry 3

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,299

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:33 UTC
BENEVICH ERICChief Commercial Officer
SaleCommon Stock 5,479 $139.38 $763,656.99
Disclosure

SEC source: 0000914475-24-000096 · wk-form4_1710538413.xml · nonDerivative · entry 2

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,778

F2 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $137.83 to $142.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:33 UTC
BENEVICH ERICChief Commercial Officer
Exercise / conversionCommon Stock 5,479 $79.02 $432,950.58
Disclosure

SEC source: 0000914475-24-000096 · wk-form4_1710538413.xml · nonDerivative · entry 1

BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,257

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes an aggregate of 162 shares purchased on February 29, 2024 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:25 UTC Exercise / conversionNon-Qualified Stock Option · Derivative 20,000 $39.79 Strike: $39.79 $795,800.00
Disclosure

SEC source: 0000914475-24-000094 · wk-form4_1710537915.xml · derivative · entry 6

MORROW GEORGE J · CIK 0001068754 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2025-09-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option granted September 30, 2015 and vests in 36 equal monthly installments.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 21:25 UTC Exercise / conversionNon-Qualified Stock Option · Derivative 20,000 $39.79 Strike: $39.79 $795,800.00
Disclosure

SEC source: 0000914475-24-000094 · wk-form4_1710537915.xml · derivative · entry 5

MORROW GEORGE J · CIK 0001068754 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2025-09-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option granted September 30, 2015 and vests in 36 equal monthly installments.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.